Prophylaxis setting
Showing 1 - 25 of >10,000
EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in
Recruiting
- COVID-19
-
Abu Dhabi, United Arab Emirates
- +1 more
Jul 20, 2022
Pre-Exposure Prophylaxis (PrEP) Trial in Baltimore (PrEP-RN)
Completed
- Pre-Exposure Prophylaxis (PrEP)
- PrEP-RN
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Mar 30, 2022
Teenagers and Hereditary Angioedema Type I or Type II Who Use
Completed
- Hereditary Angioedema (HAE)
-
Graz, Austria
- +19 more
Jan 12, 2023
Knowledge, Attitudes, Practice, Post-exposure Prophylaxis Trial in Toronto, Arua (Participatory Comic Intervention)
Completed
- Knowledge, Attitudes, Practice
- Post-exposure Prophylaxis
- Participatory Comic Intervention
-
Toronto, Ontario, Canada
- +1 more
Dec 23, 2021
Pre-Exposure Prophylaxis, STI, Contraceptive Usage Trial in Durban (Provision of sexual health preventative services in the
Recruiting
- Pre-Exposure Prophylaxis
- +2 more
- Provision of sexual health preventative services in the salon setting
-
Durban, South AfricaIthembalabantu People's Hope Clinic
Jan 10, 2022
COVID19, Coronavirus, Acute Respiratory Illnesses Trial in Worldwide (Chloroquine or Hydroxychloroquine, Placebo)
Completed
- COVID19
- +2 more
- Chloroquine or Hydroxychloroquine
- Placebo
-
Abomey-Calavi, Benin
- +24 more
Jan 10, 2023
Hemophilia B, Hemophilia A Trial in Worldwide (Standard of Care FIX Replacement therapy, Standard of Care FVIII Replacement
Recruiting
- Hemophilia B
- Hemophilia A
- Standard of Care FIX Replacement therapy
- Standard of Care FVIII Replacement therapy
-
Palo Alto, California
- +77 more
Dec 29, 2022
Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])
Not yet recruiting
- Cytomegalovirus Infections
- Transplant-Related Disorder
- Letermovir 480 MG [Prevymis]
-
Philadelphia, PennsylvaniaPenn Medicine at the University of Pennsylvania
Sep 27, 2023
Urinary Tract Infections, Stent Related Infection Trial in Gent (Double-J stent removal)
Recruiting
- Urinary Tract Infections
- Stent Related Infection
- Double-J stent removal
-
Gent, Eastern-Flanders, BelgiumUniversity Hospital Ghent
Dec 19, 2022
Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)
Not yet recruiting
- Hematological Malignancy
- Neutropenia
-
Morgantown, West VirginiaAaron Cumpston
Sep 12, 2022
Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism Trial (The multifaceted interventions, Routine VTE
Recruiting
- Venous Thromboembolic Disease
- +4 more
- The multifaceted interventions
- Routine VTE prophylaxis
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jan 19, 2023
HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir
Not yet recruiting
- HIV
- Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
- (no location specified)
Nov 13, 2023
Pancreaticoduodenectomy, Antibiotherapy Trial (Antibioprophylaxis (Piperacillin-tazobactam), 5 days Antibiotherapy
Not yet recruiting
- Pancreaticoduodenectomy
- Antibiotherapy
- Antibioprophylaxis (Piperacillin-tazobactam)
- 5 days Antibiotherapy (Piperacillin-tazobactam)
- (no location specified)
Nov 3, 2023
Ascites Infection Trial in Cairo (Rifaximin 550 milligram Oral Tablet [XIFAXAN])
Completed
- Ascites Infection
- Rifaximin 550 milligram Oral Tablet [XIFAXAN]
-
Cairo, Egyptfaculty of medicine Ain Shams university
Nov 17, 2022
HIV Trial in Baltimore (CHECKIT!)
Recruiting
- HIV Infections
- CHECKIT!
-
Baltimore, MarylandJohns Hopkins School of Public Health
Aug 3, 2023
Fluoroquinolone Resistance Prevalence Study
Recruiting
- Multiple Myeloma
-
Washington, District of Columbia
- +1 more
Apr 10, 2023
The CATALYST Study
Recruiting
- HIV Prevention
-
Kisumu, Kenya
- +27 more
Jun 30, 2023
Implantable Long-Acting Pre-Exposure Prophylaxis For MSM
Not yet recruiting
- HIV Prevention
- No intervention
-
Austin, TexasDell Medical School, UT-Austin
Dec 30, 2022
Previously Treated Advanced/Metastatic HER2-positive Breast
Recruiting
- HER2-positive Breast Cancer
- Trastuzumab deruxtecan
-
Naples, Italy
- +17 more
Jan 31, 2023
Implementation and Delivery of Cabotegravir Long Acting
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
-
Seattle, Washington
- +1 more
May 16, 2023
A Multi-Centre, Single-arm, Observational Study of EVUSHELD in
Active, not recruiting
- COVID-19
-
Qionghai, Hainan, China(2) Ruijin-Hainan Hospital Shanghai Jiaotong University School o
Jun 21, 2023